Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
作者:
Angela M,Araujo [1]
;
Andrea,Abaurrea [1]
;
Peio,Azcoaga [1]
;
Joanna I,López-Velazco [1]
;
Sara,Manzano [1]
;
Javier,Rodriguez [2]
;
Ricardo,Rezola [3]
;
Leire,Egia-Mendikute [4]
;
Fátima,Valdés-Mora [5]
;
Juana M,Flores [6]
;
Liam,Jenkins [7]
;
Laura,Pulido [1]
;
Iñaki,Osorio-Querejeta [1]
;
Patricia,Fernández-Nogueira [8]
;
Nicola,Ferrari [9]
;
Cristina,Viera [10]
;
Natalia,Martín-Martín [11]
;
Alexandar,Tzankov [12]
;
Serenella,Eppenberger-Castori [12]
;
Isabel,Alvarez-Lopez [13]
;
Ander,Urruticoechea [13]
;
Paloma,Bragado [14]
;
Nicholas,Coleman [15]
;
Asís,Palazón [16]
;
Arkaitz,Carracedo [17]
;
David,Gallego-Ortega [18]
;
Fernando,Calvo [19]
;
Clare M,Isacke [7]
;
María M,Caffarel [20]
;
Charles H,Lawrie [21]
作者单位:
Biodonostia Health Research Institute, San Sebastian, Spain.
[1]
Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.
[2]
Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain.
[3]
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
[4]
Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Sydney, New South Wales, Australia.;School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
[5]
Department of Animal Medicine and Surgery, Complutense University of Madrid, Madrid, Spain.
[6]
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
[7]
Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine and.;Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
[8]
Tumour Microenvironment Lab, The Institute of Cancer Research, London, United Kingdom.
[9]
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.;CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.
[10]
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.;CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.;Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Bizkaia, Spain.
[11]
Institute of Medical Genetics and Pathology, University Hospital, Basel, Switzerland.
[12]
Biodonostia Health Research Institute, San Sebastian, Spain.;Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, San Sebastian, Spain.
[13]
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.;Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
[14]
Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
[15]
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.;IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
[16]
Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.;CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain.;Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Bizkaia, Spain.;IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.;Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, Bilbao, Spain.
[17]
Tumour Development Laboratory, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, New South Wales, Sydney, Australia.;St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.;School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Sydney, New South Wales, Australia.
[18]
Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.;Tumour Microenvironment Lab, The Institute of Cancer Research, London, United Kingdom.
[19]
Biodonostia Health Research Institute, San Sebastian, Spain.;IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
[20]
Biodonostia Health Research Institute, San Sebastian, Spain.;IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.;Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
[21]
主题词
动物(Animals);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);成纤维细胞(Fibroblasts);人类(Humans);小鼠(Mice);抑瘤素M(Oncostatin M);信号传导(Signal Transduction);肿瘤微环境(Tumor Microenvironment)
DOI
10.1172/JCI148667
PMID
35192545
发布时间
2024-08-01
- 浏览0

The Journal of clinical investigation
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文